Cargando…
Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis
Amongst the most prevalent malignancies worldwide, head and neck squamous cell carcinoma (HNSCC) is characterized by high morbidity and mortality. The failure of standard treatment modalities, such as surgery, radiotherapy, and chemotherapy, demands the need for in-depth understanding of the complex...
Autores principales: | Khedkar, Harshita Nivrutti, Chen, Lung-Ching, Kuo, Yu-Cheng, Wu, Alexander T. H., Huang, Hsu-Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299157/ https://www.ncbi.nlm.nih.gov/pubmed/37373393 http://dx.doi.org/10.3390/ijms241210247 |
Ejemplares similares
-
HNC0014, a Multi-Targeted Small-Molecule, Inhibits Head and Neck Squamous Cell Carcinoma by Suppressing c-Met/STAT3/CD44/PD-L1 Oncoimmune Signature and Eliciting Antitumor Immune Responses
por: Lee, Jih-Chin, et al.
Publicado: (2020) -
Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria
por: Oga, Emmanuel A., et al.
Publicado: (2016) -
Salivary Cytokines in patients with Head and Neck Cancer (HNC) treated with Radiotherapy
por: Principe, Sara, et al.
Publicado: (2019) -
BMSC–HNC Interaction: Exploring Effects on Bone Integrity and Head and Neck Cancer Progression
por: Eichberger, Jonas, et al.
Publicado: (2023) -
In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1
por: Khedkar, Harshita Nivrutti, et al.
Publicado: (2021)